| Identification | |
| Name: | N-Deshydroxyethyl Dasatinib |
| Synonyms: | N-(2-Chloro-6-methylphenyl)-2-[[2-methyl-6-(1-piperazinyl)-4-pyrimidinyl]amino]-5-thiazolecarboxamide;N-Deshydroxyethyl Dasatinib;Dasatinib metabolite M4 |
| CAS: | 910297-51-7 |
| Molecular Formula: | C20H22ClN7OS |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C20H22ClN7OS/c1-12-4-3-5-14(21)18(12)27-19(29)15-11-23-20(30-15)26-16-10-17(25-13(2)24-16)28-8-6-22-7-9-28/h3-5,10-11,22H,6-9H2,1-2H3,(H,27,29)(H,23,24,25,26) |
| Molecular Structure: | ![(C20H22ClN7OS) N-(2-Chloro-6-methylphenyl)-2-[[2-methyl-6-(1-piperazinyl)-4-pyrimidinyl]amino]-5-thiazolecarboxamid...](https://img.guidechem.com/structure/910297-51-7.gif) |
| Properties | |
| Density: | 1.404g/cm3 |
| Refractive index: | 1.69 |
| Usage: | A metabolite of Dasatinib. Used in the treatment of cancers and immune diseases |
| Safety Data | |
 |
|
